Lung Cancers Terminated Phase 1 Trials for Sorafenib (DB00398)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00543335Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung CancerTreatment